Page results
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
The Macmillan Support and Information Service celebrates its developments and achievements since opening ten years ago.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
The Secretary of State for Health and Social Care, The Rt. Hon. Sajid Javid MP visited the National Hospital for Neurology and Neurosurgery (NHNN), earlier this week (Wednesday 4 May 2022).
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
File results
-
FOI/2022/0592 - A&E/ document management/ digital dictation/ scheduling IT systems
-
FOI/2022/0594 - Hotels and taxis for out-of-area patients and their next of kin
-
FOI/2022/0601 - Admission for babies declined for level 3 neonatal intensive care unit
-
FOI/2022/0602 - Number of patients admitted for lung diseases over a five year period
-
FOI/2022/0606 - Breathing circuits supplier
-
FOI/2022/0608 - Patient experience feedback
-
FOI/2022/0609 - Parking for patents/ carers for children/ young people with cancer
-
FOI/2022/0611 - FTE staff, student staff, patients and attendances, bed numbers and occupancy
-
FOI/2022/0612 - Blood transfusions from patients vaccinated with mRNA gene therapy Coronavirus
-
FOI/2022/0660 - Prostate cancer